Square Pharmaceuticals PLC. has informed that the Board of Directors in its meeting held on July 12, 2023 has approved an agreement with M/s Aristopharma Ltd. for contract manufacturing of some products on behalf of the company to meet increased demand of existing products and to introduce new products.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
211.8 BDT | +1.05% |
|
-0.38% | +0.71% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.71% | 1.6B | |
+54.07% | 809B | |
+39.38% | 624B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.77% | 240B | |
+0.57% | 219B | |
+14.80% | 220B | |
+7.42% | 166B |
- Stock Market
- Equities
- SQURPHARMA Stock
- News Square Pharmaceuticals PLC.
- Square Pharmaceuticals PLC Announces Contract Manufacturing Agreement with M/S Aristopharma Ltd